Placental gene expression patterns of endoglin (CD105) in intrauterine growth restriction

References

• Wollmann HA. Intrauterine growth restriction: definition and etiology. Horm Res 1988;49:1–6
   Google Scholar
• Marconi AM, Cetin I, Davoli E, et al. An evaluation of fetal glucogenesis in intrauterine growth-retarded pregnancies. Metabolism 1993;42:860–4
   PubMed Web of Science ®Google Scholar
• Magnusson AL, Powell T, Wennergren M, et al. Glucose metabolism in the human preterm and term placenta of IUGR fetuses. Placenta 2004;25:337–46
   PubMed Web of Science ®Google Scholar
• Economides DL, Nicolaides KH. Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. Am J Obstet Gynecol 1989;160:385–9
   PubMed Web of Science ®Google Scholar
• Sheikh S, Satoskar P, Bhartiya D. Expression of insulin-like growth factor-I and placental growth hormone mRNA in placentae: a comparison between normal and intrauterine growth retardation pregnancies. Mol Hum Reprod 2001;7:287–92
   PubMed Web of Science ®Google Scholar
• Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm Res 1997;48:11–16
   PubMed Web of Science ®Google Scholar
• Maulik D, Frances Evans J, Ragolia L. Fetal growth restriction: pathogenic mechanisms. Clin Obstet Gynecol 2006;49:219–2
   PubMed Web of Science ®Google Scholar
• Arroyo JA, Winn VD. Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatol 2008;32:172–7
   PubMed Web of Science ®Google Scholar
• Ahmed A, Perkins J. Angiogenesis and intrauterine growth restriction. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:981–98
   PubMed Web of Science ®Google Scholar
• Pardi G, Marconi AM, Cetin I. Pathophysiology of intrauterine growth retardation: role of the placenta. Acta Paediatr Suppl 1997;423:170–2
   PubMedGoogle Scholar
• Demir R, Seval Y, Huppertz B. Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem 2007;109:257–65
   PubMed Web of Science ®Google Scholar
• Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004;25:127–39
   PubMed Web of Science ®Google Scholar
• Gougos A, Letarte M. Primary structure of endoglin; an RDG-conatining glycoprotein of human endothelial cells. J Biol Chem 1990;265:8361–4
   PubMed Web of Science ®Google Scholar
• Ten Dijke P, Goumans M, Pardali E. Endoglin in angiogenesis and vascular diseases. Angiogenesis 2008;11:79–89
   PubMed Web of Science ®Google Scholar
• Van Laake LW, van den Driesche S, Post S, et al. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 2006;114:2288–97
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang Y, Hong H. Multimodality molecular imaging of CD105 (endoglin) expression. Int J Clin Exp Med 2011;4:32–42
   PubMedGoogle Scholar
• Ten Dijke P, Arthur HM. Extracellular controll of TGF-beta signalling in vascular development and disease. Nat Rev Mol Cell Biol 2007;8:857–69
   PubMed Web of Science ®Google Scholar
• Arthur HM, Ure J, Smith AJ, et al. Endoglin, an ancillary TGF-beta receptor, is rerquired for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 2000;217:42–53
   PubMed Web of Science ®Google Scholar
• Yinon Y, Kingdom JCP, Odutayo A, et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction. Circulation 2010;122:1846–53
   PubMed Web of Science ®Google Scholar
• Wallner W, Sengenberger R, Strick R, et al. Angiogenetic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci 2007;112:51–7
   PubMed Web of Science ®Google Scholar
• Asvold BO, Vatten LJ, Romundstad PR, et al. Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am J Epidemiol 2011;173:630–9
   PubMed Web of Science ®Google Scholar
• Laskowska M, Laskowska K, Oleszczuk J. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and heatlhy pregnant women. J Mat Fet Neonat Med 2012;25:806–81
   PubMed Web of Science ®Google Scholar
• Ramsay JE, Ferrell WR, Crawford L, et al. Divergent metabolic and vascular phenotypes in preeclampsia and intrauterine growth restriction. J Hypertens 2004;22:2177–83
   PubMed Web of Science ®Google Scholar
• Stepan H, Kramer T, Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrin Metab 2007;92:2831–4
   PubMed Web of Science ®Google Scholar
• Yinon Y, Nevo O, Xu J, et al. Severe intrauterine growth restriction pregnancies have increased placental endoglin levels. Am J Path 2008;172:77–85
   PubMed Web of Science ®Google Scholar
• Jeyabalan A, McGonigal S, Gilmour C, et al. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta 2008;29:555–63
   PubMed Web of Science ®Google Scholar
• Szentpéteri I, Rab A, Kornya L, et al. Gene expression patterns of vascular endothelial growth factor (VEGF-A) in human placenta from pregnancies with intrauterine growth restriction. J Mat Fet Neonat Med 2013;26:984--989
   Google Scholar
• Chen CP, Bajoria R, Aplin JD. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol 2002;187:764–9
   PubMed Web of Science ®Google Scholar
• Elhawary TM, El-Bandary AS, Demerdash H. Maternal serum endoglin as an early marker of preeclampsia in high risk patients. Int J Women Health 2012;4:521–5
   Google Scholar